Compare JPMorgan Chase & Co (JPM) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Chase & Co vs McKesson Corporation — how do they compare? JPMorgan Chase & Co trades at $343.81 (market cap $906.71B), while McKesson Corporation trades at $832.08 (market cap $98.51B). The key difference: JPMorgan Chase & Co is far larger — about 9.2× McKesson Corporation's market cap, and JPMorgan Chase & Co pays the higher dividend (1.76%). Which is the better fit depends on your goals.
| JPM | MCK | |
|---|---|---|
Market Cap | $906.71B | $98.51B |
Volume | 10,479,943 | — |
Sector | Financials | Health |
52-Week High | $346.91 | $995.69 |
52-Week Low | $282.84 | $659.01 |
Dividend Yield | 1.76% | 0.39% |
Enterprise Value | — | $103.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JPMorgan Chase (JPM) trades at $341.10, down 0.6% on the day, with a bullish technical signal from moving averages and neutral oscillators. The stock shows strong fundamentals with revenue growing from $128.6B in 2022 to $181.8B in 2025, though net income dipped slightly to $57.05B in 2025. Recent earnings beat expectations in Q1 and Q2 2026, with Q3 results pending. Analyst consensus is 'Moderate Buy' with a $374 price target, representing 9.6% upside from current levels.
Outlook remains positive with continued revenue growth projected to $194.8B in 2026 and improving profit margins. Key opportunities include banking sector strength and consistent dividend payments, while risks involve geopolitical uncertainty, cybersecurity threats from advanced AI, and CEO Jamie Dimon's warnings about market risks. The stock trades at reasonable valuations with P/E of 14.61 and P/B of 2.56.
McKesson (MCK) trades at $841.39, showing minimal daily movement with a 0.01% gain. The stock maintains strong technical momentum with bullish moving averages and sits above key support at $834. Fundamentally, the company demonstrates consistent revenue growth reaching $359.05B in 2025 and has beaten earnings expectations for three consecutive quarters. Analyst sentiment remains overwhelmingly positive with 80% buy ratings and a $932.83 consensus price target representing 11% upside potential.
MCK presents a compelling investment case driven by strong fundamentals and positive analyst coverage, though investors should monitor the company's thin profit margins (1.18% net margin) and execution risks in a competitive healthcare distribution market. The stock's current valuation at 21.92 P/E appears reasonable given growth prospects, but regulatory pressures and macroeconomic factors could impact performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
